Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Viral”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00135798
What this trial is testing

Pre-Transplant Treatment to Prevent Recurrence of Hepatitis C After Liver Transplantation

Who this might be right for
Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 79
Not applicableUnknownNCT04886102
What this trial is testing

Molecular Epidemiology of Hepatitis B in Cayenne General Hospital, French Guiana

Who this might be right for
Hepatitis B, ChronicAdults
Centre Hospitalier de Cayenne 400
Early research (Phase 1)Study completedNCT00782353
What this trial is testing

Safety, Tolerability, and Antiviral Activity of ANA598 in Patients With Genotype-1 Chronic HCV Infection

Who this might be right for
Chronic Hepatitis C
Hoffmann-La Roche 35
Not applicableStudy completedNCT04094272
What this trial is testing

Pulmonary Arterial Hypertension in Patients With Direct-Acting Antiviral Medications for Hepatitis C Virus Infection

Who this might be right for
Pulmonary Artery HypertensionChronic Hepatitis c
Kantonsspital Olten 49
Testing effectiveness (Phase 2)WithdrawnNCT01430000
What this trial is testing

Safety and Efficacy of Sustained Interferon Alfa 2b (INF) Therapy of Relapsing Hepatitis C (HCV) Patients Using InfraDure Biopump

Who this might be right for
Hepatitis C
Medgenics Medical Israel Ltd.
Early research (Phase 1)UnknownNCT00300807
What this trial is testing

Study of XTL6865 in Patients With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C
XTL Biopharmaceuticals 36
Early research (Phase 1)Study completedNCT04201275
What this trial is testing

The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC74647 in HCV-infected Subjects

Who this might be right for
Chronic Hepatitis C
Sunshine Lake Pharma Co., Ltd. 28
Not applicableStudy completedNCT03992313
What this trial is testing

Community Versus Facility-based Services to Improve the Screening of Active HCV Infection in Cambodia

Who this might be right for
Hepatitis CTesting
ANRS, Emerging Infectious Diseases 7,692
Not applicableStudy completedNCT03880682
What this trial is testing

Direct Acting Antivirals for HCV Infection in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant; ComplicationsHepatitis C, Chronic
Istanbul University 30
Testing effectiveness (Phase 2)Study completedNCT01314261
What this trial is testing

Study of ABT-267 in Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Infected Subjects

Who this might be right for
Chronic Hepatitis CHepatitis C Virus (HCV) Infection
AbbVie (prior sponsor, Abbott) 37
Large-scale testing (Phase 3)Study completedNCT01513941
What this trial is testing

An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1)

Who this might be right for
Chronic Hepatitis C
Janssen-Cilag International NV 163
Not applicableStudy completedNCT03181074
What this trial is testing

Early Post-marketing Study of Daclatasvir (Daklinza) in the Treatment of Chronic Hepatitis C (CHC) in Adults

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 10
Not applicableNo Longer AvailableNCT02097966
What this trial is testing

EU: A Multicenter Compassionate Use Program of Daclatasvir (BMS-790052) in Combination With Sofosbuvir With or Without Ribavirin for the Treatment of Subjects With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb
Early research (Phase 1)Study completedNCT01253551
What this trial is testing

VX-950HEP1001 - Drug-drug Interaction Study Between Telaprevir and Raltegravir

Who this might be right for
Hepatitis C
Tibotec BVBA 21
Large-scale testing (Phase 3)Study completedNCT02219490
What this trial is testing

Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Hepatitis C Virus (HCV) Infection Genotype 1
AbbVie 1,596
Not applicableStudy completedNCT03579576
What this trial is testing

Simplified Antiviral Treatment Strategy for Hepatitis C in Myanmar

Who this might be right for
Hepatitis CHepatitis BHIV Infections
Right to Care 803
Not applicableStudy completedNCT00037076
What this trial is testing

Prevalence of Hepatitis C Virus Infection in HIV-Infected Children

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 600
Not applicableStudy completedNCT00004850
What this trial is testing

Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection

Who this might be right for
Hepatitis CHepatitis B
National Institutes of Health Clinical Center (CC) 805
Early research (Phase 1)Study completedNCT02095860
What this trial is testing

Food Effect of a Fixed Dose Combination of Daclatasvir, Asunaprevir and BMS-791325

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 24
Early research (Phase 1)Study completedNCT00904059
What this trial is testing

Drug-Drug Interaction Study in Healthy Subjects

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 28
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation